Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kindly MD, Inc. - Common Stock (NQ:KDLY)

24.94 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kindly MD, Inc. - Common Stock

< Previous 1 2 3 Next >
KindlyMD(TM) to Participate in Upcoming October Conferences
Via ACCESSWIRE
KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024
Via ACCESSWIRE
KindlyMD(TM) Appoints Jeremy Joyal, MD as Medical Director
Via ACCESSWIRE
KindlyMD to Participate in H.C. Wainwright’s 26th Annual Global Investment Conference on September 9-11, 2024
Via ACCESSWIRE
KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director
Via ACCESSWIRE
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
KDLY Stock Earnings: Kindly MD Reported Results for Q2 2024
Kindly MD just reported results for the second quarter of 2024. 
Via InvestorPlace
KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
Via ACCESSWIRE
KindlyMD to Present at Upcoming August 2024 Investor Conferences
Via ACCESSWIRE
KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment
KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment 
Via News Direct
Topics Cannabis Initial Public Offering
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
KindlyMD Announces First Quarter 2024 Financial Results and Provides Shareholder Update
Via ACCESSWIRE
KindlyMD Announces Successful SAM.gov Registration and Grant Application
Via ACCESSWIRE
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
 
Via Benzinga
Topics Stocks
KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling
Via ACCESSWIRE
Top 4 Cannabis Stocks to Watch Ahead of Potential Federal Policy Changes
Top 4 Cannabis Stocks to Watch Ahead of Potential Federal Policy Changes 
Via News Direct
Topics Cannabis
3 Cannabis Stocks to Buy at a 52-Week Low in July
These cannabis stocks trading near 52-week lows have tremendous upside potential amid unique tailwinds and wider sector improvements. 
Via InvestorPlace
Topics Cannabis
3 IPO Gems Flying Under the Radar (for Now)
These undervalued IPO stocks went unnoticed. But as the U.S. IPO market grows, it creates unique investment opportunities across sectors. 
Via InvestorPlace
Topics Initial Public Offering
KindlyMD(TM) is Proudly Contracted with Blue Cross Blue Shield Under Utah’s Top Insurance Payors
Via ACCESSWIRE
KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors
Via ACCESSWIRE
Here's How To Enhance Marijuana Therapies: KindlyMD And Curaleaf Collab Provide More Resources And Information To Utah Patients
Healthcare data company KindlyMD, Inc. (NASDAQ: KDLY) has teamed up with the U.S. cannabis giant Curaleaf Holdings, Inc. (TSX: CURA)(OTCQX: CURLF) to provide educational resources and information with... 
Via Benzinga
Topics Cannabis
KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah
Via ACCESSWIRE
KCSA Cannabis Virtual Investor Conference Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.